share_log

Vertex Pharmaceuticals | DEF 14A: Definitive information statements

Vertex Pharmaceuticals | DEF 14A: Definitive information statements

福泰制药 | DEF 14A：股东委托书决议
SEC announcement ·  04/04 16:07
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Incorporated announced that its 2024 Annual Meeting of Shareholders will be held virtually on May 15, 2024. Shareholders will vote on the election of directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2024, an advisory vote on 2023 executive compensation, and two shareholder proposals regarding special shareholder meeting improvement and a report on racial and gender pay gaps. The meeting will facilitate shareholder participation from any location at no cost. Shareholders of record as of March 18, 2024, are entitled to vote. The board recommends voting for the election of all director nominees, for the ratification of Ernst & Young LLP, for the 2023 named executive officer compensation, and against the shareholder proposals. The company's proxy materials are available online, and shareholders can vote by internet, telephone, or mail prior to the meeting.
Vertex Pharmaceuticals Incorporated announced that its 2024 Annual Meeting of Shareholders will be held virtually on May 15, 2024. Shareholders will vote on the election of directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2024, an advisory vote on 2023 executive compensation, and two shareholder proposals regarding special shareholder meeting improvement and a report on racial and gender pay gaps. The meeting will facilitate shareholder participation from any location at no cost. Shareholders of record as of March 18, 2024, are entitled to vote. The board recommends voting for the election of all director nominees, for the ratification of Ernst & Young LLP, for the 2023 named executive officer compensation, and against the shareholder proposals. The company's proxy materials are available online, and shareholders can vote by internet, telephone, or mail prior to the meeting.
Vertex Pharmicals Incorporated宣布，其2024年年度股东大会将于2024年5月15日虚拟举行。股东们将就董事选举、批准安永会计师事务所作为2024年独立注册会计师事务所、对2023年高管薪酬进行咨询投票、关于股东特别会议改善的两项股东提案以及关于种族和性别薪酬差距的报告进行投票。该会议将促进股东从任何地点免费参与。截至2024年3月18日的登记股东有权投票。董事会建议投票选举所有董事候选人，批准安永会计师事务所，2023年指定执行官薪酬，反对股东提议。公司的代理材料可在线获取，股东可以在会议之前通过互联网、电话或邮件进行投票。
Vertex Pharmicals Incorporated宣布，其2024年年度股东大会将于2024年5月15日虚拟举行。股东们将就董事选举、批准安永会计师事务所作为2024年独立注册会计师事务所、对2023年高管薪酬进行咨询投票、关于股东特别会议改善的两项股东提案以及关于种族和性别薪酬差距的报告进行投票。该会议将促进股东从任何地点免费参与。截至2024年3月18日的登记股东有权投票。董事会建议投票选举所有董事候选人，批准安永会计师事务所，2023年指定执行官薪酬，反对股东提议。公司的代理材料可在线获取，股东可以在会议之前通过互联网、电话或邮件进行投票。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息